Department of Biochemistry
Katrin is a PhD student in the Hollfelder lab at the Department of Biochemistry at the University of Cambridge. Before joining the Hollfelder lab, Katrin studied Biochemistry at Technical University of Munich, the National University of Singapore and ETH Zurich and was an intern at Roche in Munich. Previously, Katrin worked on projects in protein biochemistry, immuno-oncology, and synthetic biology.
Katrin's current research focuses on developing a high throughput microfluidic platform for rapid antibody discovery. The platform enables to speed up the process of finding rare antibody producing cells from several months to just weeks which can give a decisive advantage in a pandemic. Together with collaborators at the MRC Toxicology Unit and the Cambridge Institute for Therapeutic Immunology & Infectious Disease, Katrin generated antibodies against SARS-CoV-2 for diagnostic and therapeutic purposes. Katrin is passionate about developing methods to investigate the complexity of our immune system with the goal of creating novel therapies.
Katrin is a PhD student in the Hollfelder lab at the Department of Biochemistry at the University of Cambridge. Before joining the Hollfelder lab, Katrin studied Biochemistry at Technical University of Munich, the National University of Singapore and ETH Zurich and was an intern at Roche in Munich. Previously, Katrin worked on projects in protein biochemistry, immuno-oncology, and synthetic biology.
Katrin's current research focuses on developing a high throughput microfluidic platform for rapid antibody discovery. The platform enables to speed up the process of finding rare antibody producing cells from several months to just weeks which can give a decisive advantage in a pandemic. Together with collaborators at the MRC Toxicology Unit and the Cambridge Institute for Therapeutic Immunology & Infectious Disease, Katrin generated antibodies against SARS-CoV-2 for diagnostic and therapeutic purposes. Katrin is passionate about developing methods to investigate the complexity of our immune system with the goal of creating novel therapies.
I have started this project myself and generated and tested mouse and human antibodies against SARS-CoV-2. Immunised mice and patient samples were provided by collaborators at the MRC Toxicology Unit. For further antibody characterisation, I have initiated collaborations within the Biochemistry Department and the Cambridge Institute for Therapeutic Immunology & Infectious Disease.
Other 2022 award winners
Filip Boskovic
Teresa Brevini
Ana Gatoo Jimenez de Laiglesia
Chengzi Guo
Nomisha Kurian
Rakoen Marieke Maertens
Katerina Naydenova
Clayton Roberts
Benjamin Tuck
Vaithish Velazhahan
Clara Wanjura